Nephrotic syndrome associated with hyper-high-density lipoproteinemia potentiated by prednisolone therapy.

Abstract

We describe a case of nephrotic syndrome (idiopathic membranous glomerulonephropathy) with high serum HDL cholesterol (91 mg/100 ml) which increased to 240 mg/100 ml following steroid therapy. The increase in HDL was mainly a result of increased HDL2 and increased plasma apolipoprotein A-I.

• Authors: J Sasaki, F Hara, T Motooka, S Naito, K Arakawa
• Journal: Nephron (Nephron) Vol. 41 Issue 1 Pg. 110-3 ( 1985) ISSN: 1660-8151 [Print] Switzerland
• PMID: 3929150 (Publication Type: Case Reports, Journal Article)

Chemical References

• Apolipoprotein A-I
• Apolipoproteins A
• Cholesterol, HDL
• Prednisolone

Topics

• Adult
• Apolipoprotein A-I
• Apolipoproteins A (blood)
• Chemical and Drug Induced Liver Injury
• Cholesterol, HDL (blood)
• Humans
• Hyperlipoproteinemias (blood, chemically induced, complications)
• Liver Diseases (blood)
• Male
• Nephrotic Syndrome (blood, complications, drug therapy)
• Prednisolone (adverse effects, therapeutic use)